TEVAR Coding Guide...configura ons for fusiform and saccular aneurysms/penetra ng ulcers. Contraindica ons The Valiant Navion thoracic stent gra system is contraindicated in the following
This document is posted to help you gain knowledge. Please leave a comment to let me know what you think about it! Share it to your friends and learn new things together.
Transcript
2019 TEVAR Coding Guide
PHYSICIAN:
DATE OF PROCEDURE:
PATIENT NAME:
PRINCIPAL DIAGNOSIS:
I71.01 — Dissec on of thoracic aorta
I71.1 — Thoracic Aor c Aneurysm ruptured
I71.2 — Thoracic Aor c Aneurysm without rupture
SECONDARY DIAGNOSIS:
S25.00XA, S25.01XA, S25.02XA, S25.09XA (unspecified or lacera on may apply)
37242 Art. emboliza on or coiling (non‐hemorrhage or tumor) 9.80 ‐ ‐51 ‐ ‐80 ‐82 ‐AS
37236 Non‐coronary arterial stent, ini al artery 8.75 ‐50 ‐51 ‐ ‐ ‐ ‐
33889 Transposi on; open sub‐c to caro d, neck incision with TAA 15.92 ‐50 ‐51 ‐62 ‐80 ‐82 ‐AS
33891 Caro d‐caro d bypass gra , in conjunc on with TAA 20.00 ‐50 ‐51 ‐62 ‐80 ‐82 ‐AS
34712 Trans cath delivery of enhanced fixa on device 12.00 ‐ ‐51 ‐62 ‐80 ‐82 ‐AS
*Other coding modifiers may apply. These sugges ons do not replace seeking coding advice from the payer and/or your coding staff, the provider of services is ul mately responsible for correct coding.
CPT® is a trademark of the American Medical Associa on
Indica ons The Valiant Navion™ thoracic stent gra system is indicated for the endovascular repair of all lesions of the descending thoracic aorta (DTA) in pa ents having the appropriate anatomy including: iliac or femoral artery access vessel morphology that is compa ble with vascular
access techniques, devices, or accessories; nonaneurysmal aor c diameter in the range of:
16 mm to 42 mm for fusiform and saccular aneurysms/penetra ng ulcers
16 mm to 44 mm for blunt trauma c aor c injuries 19 mm to 45 mm for dissec ons;
proximal landing zone (nonaneurysmal aor c proximal neck length for fusiform and saccular aneurysms/penetra ng ulcers or nondissected length of aorta proximal to the primary entry tear for blunt trauma c aor c injuries and dissec‐ons) of:
≥ 20 mm for FreeFlo configura on ≥ 25 mm for CoveredSeal configura on; and
nonaneurysmal aor c distal neck length ≥ 20 mm for FreeFlo and CoveredSeal configura ons for fusiform and saccular aneurysms/penetra ng ulcers.
Contraindica ons The Valiant Navion thoracic stent gra system is contraindicated in the following pa ent popula ons: Pa ents who have a condi on that threatens to infect the gra Pa ents who are sensi ve to or have allergies to the device materials Warnings and Precau ons The long‐term safety and effec veness of the Valiant Navion thoracic stent gra
system has not been established. All pa ents should be advised that endovascu‐lar treatment requires lifelong, regular follow‐up to assess the integrity and performance of the implanted endovascular stent gra . Specific follow‐up guidelines are described in the Instruc ons for Use. Of note, pa ents with spe‐cific clinical findings should receive enhanced follow‐up.
The Valiant Navion thoracic stent gra system is not recommended in pa ents who cannot undergo, or who will not be compliant with, the necessary preoper‐a ve and postopera ve imaging and implanta on procedures described in the Instruc ons for Use.
The safety and effec veness of Valiant Navion thoracic stent gra system has not been evaluated in certain pa ent situa ons and/or popula ons. Please refer to product Instruc ons for Use for details.
Strictly adhere to the Valiant Navion thoracic stent gra system sizing configura‐ons and guidelines as described in the Instruc ons for Use when selec ng the
device size. The appropriate device oversizing is incorporated into the sizing guidelines. Sizing outside of this range can poten ally result in endoleak, frac‐ture, migra on, infolding, or gra wear.
Never use a balloon when trea ng a dissec on. Please refer to the product Instruc ons for Use for details. MRI Safety and Compa bility MRI may be used on the Valiant Navion thoracic stent gra only under specific condi‐ons. It can be scanned safely in both 1.5T & 3.0T MR systems under certain condi‐ons as described in the product Instruc ons for Use. For addi onal informa on
regarding MRI please refer to the product Instruc ons for Use.
Adverse Events Adverse events or complica ons associated with the use of the Valiant Navion thoracic stent gra system that may occur or require interven on include, but are not limited to: Access failure; Access site complica ons (for example: spasm, trauma, bleeding, rupture, dissec on); Adynamic Ileus; Allergic reac on (to contrast, an platelet therapy, stent gra material); Amputa on; Anaphylaxis; Anesthe c complica ons; Aneurysm rupture; Angina; Aor c expansion (for example: aneurysm, false lumen); Aor c valve damage; Aor c vessel rupture; Arrhythmia; Arterial stenosis; Atelectasis; Balloon rupture; Blindness; Bowel ischemia; Bowel necrosis; Bowel obstruc on; Branch vessel occlusion; Breakage of the metal por on of the device; Bu ock claudica on; Cardiac tamponade; Catheter breakage; Cerebrovascular accident (CVA)/Stroke; Change in mental status; Coagulopathy; Conges ve heart failure; Contrast toxicity; Conversion to surgical repair; Damage to the vessel; Death; Deployment difficul es/failures; Dissec on, perfora on, or rupture of the aor c vessel & surrounding vascula‐ture; Embolism; Endoleaks; Excessive or inappropriate radia on exposure; Ex‐trusion/erosion; Failure to deliver the stent gra ; Femoral neuropathy; Fistula (including aortobronchia, aortoenteric, aortoesophogeal, arteriovenous, and lymph); Gastrointes nal bleeding/complica ons; Genitourinary complica ons; Hematoma; Hemorrhage/bleeding; Hypotension/hypertension; Infec on or fever; Inser on or removal difficulty; Intercostal pain; Intramural hematoma; Leg edema/foot edema; Loss of patency; Lymphocele; Myocardial infarc on; Neck enlargement; Nerve injury; Neuropathy; Occlusion ‐ Venous or Arterial; Pain/reac on at catheter inser on site; Paralysis; Paraparesis; Paraplegia; Pares‐thesia; Perfusion of the false lumen; Peripheral ischemia; Peripheral nerve inju‐ry; Pneumonia; Pos mplant syndrome; Post‐procedural bleeding; Procedural bleeding; Prosthesis dilata on; Prosthesis infec on; Prosthesis rupture; Prosthe‐sis thrombosis; Pseudoaneurysm; Pulmonary edema; Pulmonary embolism; Reac on to anesthesia; Renal failure; Renal insufficiency; Reopera on; Respira‐tory depression or failure; Retrograde type A dissec on; Sepsis; Seroma; Sexual dysfunc on; Shock; Spinal neurological deficit; Stenosis; Stent gra migra on; Stent gra misplacement; Stent gra occlusion; Stent gra rupture (for exam‐ple: holes, tears); Stent gra twis ng or kinking; Transient ischemic a ack (TIA); Thrombosis; Tissue necrosis; Vascular ischemia; Vascular trauma; Wound dehis‐cence; Wound healing complica ons and Wound infec on. Please reference the product Instruc ons for Use for more informa on regard‐ing indica ons, warnings, precau ons, contraindica ons and adverse events. CAUTION: Federal (USA) law restricts this device to sale by or on the order of a physician.